CRYOPORT, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CRYOPORT, INC. stock issued during period, value, issued for services for the quarter ending 2022-03-31 was $11.50K, a 0.00% change year-over-year.
- CRYOPORT, INC. stock issued during period, value, issued for services for the quarter ending 2021-12-31 was $0.00.
- CRYOPORT, INC. stock issued during period, value, issued for services for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- CRYOPORT, INC. stock issued during period, value, issued for services for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- CRYOPORT, INC. stock issued during period, value, issued for services for fiscal 2021 was $11.50K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2022-03-31 | $11.50K 10-Q · filed 2022-05-05 | $11.50K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $11.50K 10-K · filed 2023-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | |
| 2021-03-31 | $11.50K 10-Q · filed 2021-05-06 | |
| 2020-09-30 | $20.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | |
| 2020-06-30 | $20.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | |
| 2020-03-31 | $20.70K 10-Q · filed 2021-05-06 | |
| 2019-09-30 | $20.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | |
| 2019-06-30 | $32.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | |
| 2019-03-31 | $17.50K 10-Q · filed 2020-05-08 | |
| 2018-09-30 | $17.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | |
| 2018-06-30 | $17.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | |
| 2018-03-31 | $17.50K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |